期刊文献+

uPA、uPAR和肝癌的研究进展

下载PDF
导出
作者 吕小平
出处 《内科》 2010年第2期178-179,共2页 Internal Medicine
基金 广西科学基金(桂科基0143059) 广西科技攻关基金(桂科攻0592007)
  • 相关文献

参考文献17

  • 1Nicholl SM, Roztocil E, Davies MG. Plasminogen activator system and vascular disease[J ]. Cull Vasc Pharmacol,2006,4 (2) : 101 - 116.
  • 2Idell S, Coagulation, fibrinolysis, and fibrin deposition in acute lung injnry[ J]. Crit Care Med,2003,31 (4) :213 -220.
  • 3Behrendt N. The urokinase receptor(uPAR) and the uPAR-associated protein(uPARP/Endo180) : membrane proteins engaged in matrix turnover during tissue remodeling [ J ]. Biol Chem, 2004,385 ( 2 ) : 103 - 136.
  • 4Plesner T, behrendt N, Ploug M. Structure, function and expression On blood and bone marrow cells of the urokinase-type plasminogen activator receptor,uPAR [ J]. Stem Cells, 1997,15 (6) :398 - 408.
  • 5Blasi F, Carmeliet P uPAR:aversatile signaling orchestrator[J]. Nat Rev Mol Cell Biol,2002 ,3(12) :932 -943.
  • 6Chan CF, Yau TO, Jin DY, et al. Evaluation of Nuclear Factor-KB, Urokinase-Type Plasminogen Activator, and HBx and Their Clinicopathological Significance in Hepatocellular Carcinoma [ J ]. Clin Cancer Res,2004,10(12) :4140 -4149.
  • 7Dano K, Rlomer J, Nielsen BS, et al. Cancer invasion and tissue remodeling-cooperation of protease system and cell type [ J ]. APMIS, 1999,107( 1 ) : 120 - 127.
  • 8毛华,赵敏芳,袁爱力,赖卓胜,姜文奇.血管内皮生长因子对肝癌细胞侵袭能力和同质性粘附作用影响[J].肿瘤,2002,22(3):197-199. 被引量:16
  • 9Zhou L, Hayashi Y, Itoh T, et al. Expression of urokinase-type plasminogcn activator, urokinase-type plasminogcn activator receptor and plasminogen activator inhibitor type-1 and type-2 in hcpatoceUular carcinoma [ J ]. Pathol Int, 2000,50 ( 5 ) : 392 - 397.
  • 10Dubuisson L, Monvoisin A, Nielsen BS, et al. Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma[ J]. J Pathol,2000,190 (2) :190 - 195.

二级参考文献18

  • 1蔡建春,江绍基,陈治平.细胞粘附分子与肿瘤的浸润和转移[J].上海第二医科大学学报,1993,13(2):159-163. 被引量:8
  • 2司履生,王一理.粘连分子及其在病理学中的作用[J].中华病理学杂志,1994,23(4):245-248. 被引量:19
  • 3Minagawa M, Makuuchi M, Takayama T, et al. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg, 2001,233:379-384.
  • 4Yamada K, Soejima T, Sugimoto K, et al. Pilot study of local radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Jpn J Clin Oncol, 2001, 31 : 147-152.
  • 5Ando E, Tanaka M, Yamashita F, et al. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis analysis of 48 cases. Cancer, 2002, 95 : 588-595.
  • 6Satoshi I, Takashi O, Junji F, et al. Radioherapy after transcatheter arterial chemoembilization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol, 2002, 25 : 189-193.
  • 7Chen XP, Huang ZY. Surgical treatment of hepatocellular carcinoma in china Surgical techniques, indications, and outcomes. Langenbecks Arch Surg, 2005, 390:259-265.
  • 8Sugimoto C, Saito A, Kikuzato M, et al. Angioeehographic evaluation of tumor thrombi and the effect of transcatheter arterial embolization in patients with hepatoeellular carcinoma. J Gastroenterol, 2002, 37: 363-368.
  • 9Tazawa J, Maeda M, Sakai Y, et al. Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J Gastroenterol Hepatol,2001, 16:660-665.
  • 10毛华,陈宏.影响血管内皮生长因子表达的调控因素[J].国外医学(生理病理科学与临床分册),1999,19(4):282-284. 被引量:10

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部